A new documentary directed by Billie JD Porter explores the development of the first male contraceptive pill amid shifting attitudes toward contraception and evolving gender roles in reproductive responsibility. The film follows scientists working on male contraceptive technologies and the men participating in early trials, highlighting a growing interest in expanding birth control options beyond women.
The timing coincides with changes in contraceptive use patterns in the United Kingdom, where traditional pill usage among women is declining, supplanted by alternatives like implants and intrauterine devices, while vasectomy rates are also falling. Simultaneously, many younger people are disengaging from dating altogether. Porter notes her personal disillusionment with men influenced by high-profile sexual misconduct revelations and a broader cultural reckoning, saying that her primary form of contraception recently has been avoidance based on distrust.
The male contraceptives featured in the documentary include YCT529, a pill that blocks a vitamin A receptor in the testes to halt sperm production, and another fast-acting pill that disables a protein essential for sperm motility within 30 minutes. Additionally, a sperm-suppressing gel applied to the shoulders offers a hormone-based alternative that some men may find more acceptable, especially given concerns about taking daily pills. Porter explains that some men expressed reluctance to use pills because they associate them with illness, so the gel could provide a more convenient routine.
Despite promising trial results, the path to market has been slow, attributed in part to the pharmaceutical industry's dominance in female contraception and the high barriers to entry for new products. Historically, attempts to develop male contraception have been hindered by societal expectations and skepticism—both men's reluctance to use such methods and women's uncertainty about trusting male partners to take responsibility.
Porter emphasizes this dynamic, noting that contraception traditionally places the burden of risk and management on women, reinforcing a system where men often remain detached from pregnancy prevention. However, she also highlights men actively seeking change, including one participant, Ryan, who is involved in a contraceptive gel trial. Ryan and his wife, who are Mormons and anti-abortion, view the gel as empowering, with no long-term adverse effects on sperm quality observed.
Resistance persists, particularly among men wary of ingesting hormones, a viewpoint Porter attributes partly to lack of exposure to the hormonal treatments often prescribed to teenage girls. She contrasts this hesitation with the decades women have spent coping with the side effects and anxiety of contraception, including the stress of failed condom use or uncertainty after emergency contraception.
Porter's advocacy centers on a call for equitable sharing of contraceptive responsibility, arguing that men should contribute without framing it as an act of charity. She points to the considerable physical and emotional toll pregnancy and childbirth take on women, framing male contraception as a basic fairness issue rather than an exceptional sacrifice.
The documentary also revisits the complex history of female contraception, acknowledging the extensive unpaid work and health risks women have endured to enable sexual freedom. Porter relates her own struggles with various contraceptive methods, including the pill and intrauterine devices, which caused significant side effects. A 2023 poll reflects her experience, finding that 77 percent of British women report negative side effects from the pill.
Overall, the film seeks to shed light on male contraception as both a scientific breakthrough and a potential catalyst for changing long-standing gender norms around reproductive health.